- Global Pharma News & Resources

Aqilion moves in to new premises in the Prisma office building in Helsingborg

Aqilion moves in to new premises in the Prisma office building in Helsingborg

AQILION AB is moving to the new Prisma office building in the Oceanhamnen neighborhood of Helsingborg. The new urban icon will be completed late this fall and Aqilion will move in to its new premises in January. Much of the building will house the HETCH tech hub and Aqilion will now have its headquarters in this unique environment of tech startups and established companies.

Aqilion chose Prisma and HETCH because daily contact with the Hetch concept is a good fit for a growth-phase company. An innovative environment that offers encounters, inspiration and an atmosphere that promotes growth is extremely valuable.

“Like other industries, the biotech industry is becoming digitized at a rapid pace and implementation of new technology is crucial for successful growth. I am convinced that we can gain competitive advantages by using tools from innovative tech and AI companies. Entrepreneurship often requires courage to dare to break new ground and the opportunity to exchange experiences and ideas with others who have made the same journey is invaluable. We see it as a great advantage to be able to work in a fantastic environment with a unique network, at the same time that Aqilion gets its own dedicated premises,” says Sarah Fredriksson, CEO of AQILION AB.

“Proximity to the continent and good infrastructure are important for us since we work with several international actors. By working from both Hetch in Helsingborg and Medicon Village in Lund, we can efficiently benefit from innovative tech and life science environments.”

For more information please contact:
Sarah Fredriksson, CEO, AQILION AB, + 46 (0)70 261 4575,

About Aqilion
Aqilion is a biotech company that focuses on developing new innovative treatments for diseases caused by chronic inflammation and dysfunctional immune reactions such as autoimmune diseases. The company is mainly active in the early phases of drug discovery, from idea to early clinical development.

Aqilion combines its experience from major pharmaceutical companies with the drive and entrepreneurship of small growth companies. With solid experience of business development in innovative biotech and pharmaceutical companies, Aqilion’s experienced team and board have successfully shepherded drugs all the way from discovery to market.

AQILION AB is a privately held company headquartered in Helsingborg, Sweden.

HETCH stands for “Helsingborg Tech House” and offers innovation and entrepreneurship aimed at promoting growth for startup companies in a creative environment.

HETCH is a non-profit company supported by the City of Helsingborg, Region Skåne and the business community. HETCH, which provides an ecosystem for increased innovation and growth, works with established companies and startups to provide a creative environment and a strong community. In addition to the role of accelerator and incubator, HETCH offers a unique environment in which startup companies sit wall to wall with more established growth companies.

Editor Details

Last Updated: 21-Oct-2020